In 126 colorectal cancer patients with low vitamin D after surgery (from an ongoing trial), 12 weeks of personalised vitamin D3 cut serum IL-6 by 39.3% versus placebo; changes in IFN-gamma and MMP-1 were not significant.
RCTn = 126
Gwenzi et al. Effects of personalized vitamin D3 on inflammation in colorectal cancer patients: a randomized trial